Creutzfeldt-Jakob disease: Case report and review of the literature

Acta Clinica Croatica

Volumn 49, Issue 2, 2010, Pages 181-187

  Špero, Martina ^a   Lazibat, Ines ^a  

^a University of Zagreb   (Croatia)

Author keywords

Brain pathology; Case report; Creutzfeldt Jakob syndrome diagnosis; Creutzfeldt Jakob syndrome etiology; Humans; Magentic resonance imaging; Prions

Indexed keywords

ADULT; AKINETIC MUTISM; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DEMENTIA; ELECTROENCEPHALOGRAM; FATALITY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RARE DISEASE; SYMPTOMATOLOGY; VISUAL IMPAIRMENT;

BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 78149351457     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. WILL RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003;66:255-65.
2. UKISU R, KUSHIHASHI T, TANAKA E, et al. Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics 2006;26:191-204.
3. TSCHAMPA HJ, ZERR I, URBACH H. Radiological assessment of Creutzfeldt-Jakob disease. Eur Radiol 2007;17:1200-11.
4. PARCHI P, STRAMMIELLO R, NOTARI S, et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009;118:659-71.
5. IRONSIDE JW, HEAD M. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004;284:133-59.
6. PARCHI P, GIESE A, CAPELLARI S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
7. HAMAGUCHI T, NOGUCHI-SHINOHARA M, NOZAKI I, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology 2009;29:625-31.
8. POCCHIARI M. Prevalence of variant CJD in the UK. BMJ 2009;338:b435.
9. MEAD S, POULTER M, UPHILL J, BECK J. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 2009;8:57-66.
10. LOU X, MA L, AN NY, et al. Diffusion-weighted magnetic resonance imaging in diagnosis of Creutzfeldt-Jakob disease. Chin Med 2006;119:1242-7.
11. ZERR I, KALLENBERG K, SUMMERS DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132:2659-68.
12. LODI R, PARCHI P, TONON C, et al. Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 2009;132:2669-79.
13. GLATZEL M. Biomarker profile for the diagnosis of Creutzfeldt-Jakob disease. Nature Rev Neurol 2008;4:70-1.
14. VITALI P, MIGLIACCIO R, AGOSTA F, ROSEN HJ, GESCHWIND MD. Neuroimaging in dementia. Semin Neurol 2008;28:467-83.
15. YOUNG GS, GESCHWIND MD, FISCHBEIN NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551-62.
16. MEISSNER B, KALLENBERG K, SANCHEZ-JUAN P, et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2008;29:1519-24.
17. MEISSNER B, KALLENBERG K, SANCHEZ-JUAN P, et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 2009;72:1994-2001.
18. BARRET A, TAGLIAVINI F, FORLONI G, et al. Evaluation of quinacrine treatment for prion diseases. J Virol 2003;77:8462-9.
19. TODD NV, MORROW J, DOH-URA K, et al. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J Infect 2005;50:394-6.
20. OTTO M, CEPEK L, RATZKA P, et al. Efficacy of flupirtine on cognitive function in patients with CJD. Neurology 2004;62:714-8.